Recently, several serum biomarkers such as growth differentiation factor 15 and fibroblast growth factor 21 have been reported as diagnostic indicators of mitochondrial diseases; however, a lack of validated biomarkers for diagnosing mitochondrial diseases has not been resolved15. This evidence concerns the gene FGF21 and inborn mitochondrial metabolism disorder.